Morning Endorsement: October 7, 2020 Group 10 - Subgroup 3
Morning Endorsement: October 7, 2020 Group 10 - Subgroup 3
Morning Endorsement: October 7, 2020 Group 10 - Subgroup 3
October 7, 2020
Group 10 | Subgroup 3
Differential count
% Reference (%)
Segmenters 0.74 H 0.55-0.65
Lymphocytes 0.18 L 0.25-0.35
Monocytes 0.06 0.03-0.06
Eosinophils 0.02 0.02-0.04
Basophils 0.00 0.00-0.01
Clinical Chemistry
RESULT REFERENCE
Sodium 138.10 mEq/L 135-148
Potassium 3.67 mEq/L 3.5-5.0
Blood Typing, Bleeding time and Clotting Time
RESULT REFERENCE
Prothrombin time 14.00 s 10.00-14.00 s
Activity 86% > or = 70%
INR 1.18 0.7- 1.3
Ultrasonography
•Clinical Properties
• pH: 5.5
• Specific Gravity: 1.030
• Negative Protein and Glucose
•Flowcytometry
• RBC: 0-1/HPF
• WBC: 2-4/ HPF
• Epithelial cells: FEW
• Bacteria: FEW
• Mucus Threads: MODERATE
Final Diagnosis
• Uncomplicated Acute Appendicitis (Alvarado Score: 4)
Management
• Open appendectomy – primary approach to the treatment of acute
appendicitis
• Laparoscopic appendectomy
• Longer to perform
• Less post-op pain
• Faster recovery
• Lower incisional surgical site infection rate
Management
• Antibiotic prophylaxis (Uncomplicated appendicitis)
• Recommended for the prevention of surgical site infections and intra-
abdominal abscess
• Cefoxitin 2g IV single dose
• Alternative:
• Ampicillin-sulbactam 1.5-3g IV single dose, or
• Amoxicillin-clavulanate 1.2-2.4g IV single dose
• Patients allergic to beta-lactam antibiotis:
• Gentamicin 80-120 mg IV single dose + Clindamycin 600 mg IV single dose